BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27

• Business

  Transition Therapeutics Inc. Announces Second Quarter Fiscal 2009 Financial Results

  February 12, 2009

   · 

  9 min read
• Business

  Vitrolife: Report on Operations 2008

  February 12, 2009

   · 

  1 min read
• Business

  VirtualScopics, LLC Schedules Fourth Quarter 2008 Earnings Announcement

  February 12, 2009

   · 

  3 min read
• Business

  Shengtai Pharmaceutical, Inc. Schedules 2009 Second Quarter Financial Results and Conference Call

  February 12, 2009

   · 

  3 min read
• Bio NC

  PRA International, Inc. Speaking Event: Rational Drug Design and Development in Infectious Diseases

  February 12, 2009

   · 

  1 min read
• Biotech Bay

  Odyssey Thera, Inc. Granted U.S. Patent for Novel GPCR Assay Strategy

  February 12, 2009

   · 

  1 min read
• Business

  Alcon, Inc. Fourth Quarter Diluted EPS Increased 12.8 Percent

  February 12, 2009

   · 

  1 min read
• Business

  Palatin Technologies to Report Fiscal Year 2009 Second Quarter Results; Conference Call and Webcast on February 17, 2009

  February 12, 2009

   · 

  1 min read
• Biotech Beach

  Celerus Diagnostics Secures $5 Million Series C Financing

  February 12, 2009

   · 

  1 min read
• The New England Journal of Medicine Publishes Results From Sanofi-Aventis (France)'s Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation

  February 12, 2009

   · 

  7 min read